Skip to main content

Language: English / Gàidhlig

Loading…
Chamber and committees

Health and Community Care Committee, 12 Dec 2000

Meeting date: Tuesday, December 12, 2000


Contents


Organisations (Contacts)

The Convener:

Agenda item 6 is on contacts from outside organisations. A lot of organisations continue to approach the committee and I know that members also have meetings with organisations in the area of health and community care.

The clerks' paper lists formal contacts that we have had from outside organisations. Some of them have come in fairly late in the day, so members may not have had much time, if any, to think about the organisations' comments. However, I would like to take care of all the contacts on the list this side of Christmas so, if members will bear with me, we will work our way through them.

First, we have four organisations that wish to make presentations to the committee. Lothian Primary Care NHS Trust wishes to talk to us about alcohol misuse, its impact on health and the cost to the NHS. Parliament has spent a fair amount of time over the past week or two on this issue. I am happy to make a visit as convener to the substance misuse directorate at the Royal Edinburgh hospital, if that would be acceptable to the committee. Is that agreed?

Members indicated agreement.

The Multiple Sclerosis Society of Great Britain and Northern Ireland has requested to make a presentation on multiple sclerosis.

Mary Scanlon:

I suggest that we revisit that, because I believe that the Health Technology Board for Scotland is examining care and treatment. Also, a Scottish needs assessment programme report is due. Can we look at what those people recommend, and talk to the MS Society after that?

The Convener:

We will defer the matter into the new year for further development. We can flag it up to our researchers in SPICe that we will probably come back to the issue in the first half of next year, and they should pick up any research or work that they can on it.

Next are Macmillan Cancer Relief and the Cancer Research Campaign. Members will see from their papers that I had a meeting with representatives of the CRC, who were keen to make a formal presentation to committee members. I suggested to them that on-going briefings for members on what the CRC viewed as the key issues for cancer in Scotland would be useful to members. The cancer agenda is high profile in the run-up to the cancer plan. Obviously, it is one of the priority areas, and as a committee, we have not done any specific work on cancer. Are there any comments?

Margaret Jamieson:

Two weeks ago, the first meeting took place to set up a cross-party group on cancer. Richard Simpson may wish to say something about that, because he organised the meeting. There are other cross-party groups, such as the cross-party group in the Scottish Parliament on palliative care, so we could get information from the cross-party groups.

Dr Simpson:

I was going to say that, and add that I imagine that when the health plan is published, we will want to consider how it interacts with national priorities for the delivery of health care. If we put that on our programme, we might want organisations to make presentations to us. It depends on how we consider the health plan, if indeed we decide to do it.

Shona Robison (North-East Scotland) (SNP):

I take the point about the cross-party group, but the roles of cross-party groups and of parliamentary committees are different. The letter from Macmillan Cancer Relief makes a couple of good points. One is a reiteration of the fact that cancer is one of the key priorities, and that there is an opportunity to discuss issues of concern before the cancer plan is published in March. The committee must look at the issues of concern, and take a view. The question is, do we do that before the plan, or after? The committee has a clear role to play.

Mary Scanlon:

That was my point. The first that I heard of a cancer plan was when I read the letter from Macmillan Cancer Relief. I presume that it is separate from the health plan. Is it a new initiative? The question is whether we gather information and then feed our points into the cancer plan or simply respond to it. I did not know anything about the cancer plan until I read the letter that I have in front of me.

Dorothy-Grace Elder:

We should have a presentation from both groups, and that should be given before the cancer plan is published. We could do something ourselves later. We could also gather evidence from the four or so cross-party groups whose remits concern cancer in some way or another—including chronic pain. I would recommend that we act before the plan comes out. It is a huge issue.

Is there a consultation process before the plan comes out? Can we suggest that we have an input into it?

The Convener:

We would need clarification on that. I pointed out to the Cancer Research Campaign that periodically the committee has had informal briefings, and has pulled together a number of practitioners and organisations from various fields. Such briefings have always been very useful to members, and have given the organisations and practitioners concerned an opportunity to speak bluntly and plainly to committee members.

There is also the question whether the committee feels that it would be more useful either to have a formal presentation from the two organisations that have requested it or an informal presentation, and whether it would be worth having informal discussions and presentations similar to those which we have had in the past. That might allow us to bring in a couple of other people, such as Harry Burns. By that time, we would be able to find out more about developments on the cancer plan and about any planned consultation period. We could circulate that information to members. We could do that right away, and as a result members might be able to decide whether to act before or after the publication of the plan.

Nicola Sturgeon (Glasgow) (SNP):

As a matter of principle, we should be trying wherever possible to influence Government initiatives before the relevant publications come out, rather than waiting to respond to them. I was aware that the cancer plan was scheduled to come out before March, but given that the timetable for the health plan slipped, it is possible that the cancer plan's timetable has also slipped.

We should find out immediately what that timetable is, but we should also take a decision today to get a briefing from the cancer organisations, in order to have something to say before the publication of the health plan, in the hope that we might influence it, drawing on the expert evidence and the opinions of the various cancer organisations. Part of our role is to try to influence these things when we can. Subject to our finding out the timetable, we should decide today to see the people whom we have mentioned, so that we can make a submission to the Scottish Executive, thereby trying to influence what the cancer plan says.

Following on from the point about hearing from the cancer charities, of which there are about four, I think that the breakthrough scientific research carried out at the Roslin Institute would be worth hearing about.

The Convener:

That relates to the point that I was making. If we chose to have an informal briefing, as we have occasionally done in the past, we could open that up to a larger number of organisations and practitioners than we would if we took formal evidence in committee. Our committee time will be quite precious in the early part of the year, because of our consideration of the forthcoming regulation of care bill. If members felt that an informal briefing was the best option, we could open that up to other organisations, which members could suggest.

Shona Robison:

Such a session should be held as formal evidence taking, rather than an informal briefing. That is not to diminish the importance of informal briefings but, given the importance of the plan, I would like evidence to be heard in a more formal setting.

Dorothy-Grace Elder:

On purely practical lines, I agree that evidence should be taken formally, given the vastness of the subject. Perhaps we could suggest to the major bodies concerned that they get together first, to simplify things and to save time. That would avoid duplication and ensure that major, separate points were made. The organisations would benefit from co-operating before coming before us as witnesses. That would save their time and ours—we have had some rather repetitive evidence in the past.

Dr Simpson:

I have some concerns. The regulation of care bill will be the committee's major preoccupation in January and February. If we are to tackle cancer and repeat what the Executive is doing in taking evidence from all those groups, we cannot do it in a half-hearted way; it must be done properly. That will require us to take evidence over several weeks, otherwise we will produce a half-baked report.

Members or parties might want to produce detailed work on cancer, but I do not think that the committee has the capacity to examine it in the detail that is needed between now and March.

Committee members have the paper on the timetable for the regulation of care bill; it is very tight.

Nicola Sturgeon:

I have seen a paper on the forward work plan of the committee. It might be useful to have a discussion on it at some point.

The regulation of care bill will preoccupy the committee for the first few months of next year. However, I have been on a committee that has dealt with a major piece of legislation; the rest of the world does not have to stop turning because we are examining major legislation. It might be an idea for us to turn our minds to the other work that we want to take on at the same time. It is possible to do other work.

I do not know what the plans are for the schedule of meetings next year. We are moving into a period when meeting once a fortnight will not be enough. We must have more meetings than that. When will we have an opportunity to discuss that?

The Convener:

We intend to have weekly meetings in the early part of next year, as we will be examining legislation. If we also want to consider other matters, that precludes fortnightly meetings.

The other point about the work load will come up later on today's agenda, when we consider petitions—work is continuing on a number of them. When we get to that agenda item, several reporters who are working behind the scenes might tell us that they will be able to produce a report for the committee on a certain time scale. That will lead to the committee acting on those petitions.

Work is on-going on some issues. If we were to examine cancer formally, that would introduce new work. If we were to go down the informal briefing route, it would enable us to hear from a larger number of people. It would attune the committee to the parts of the cancer agenda on which we might want to take formal evidence. We can put on a future agenda a discussion about any points that we want to have put into the cancer plan. We can decide whether we want to take formal evidence when we have had the informal briefing.

If we were to say that we would take formal evidence, we would have to hear from a whole range of people, to do it properly. That would take up a lot of time, which at the moment we do not have. That is not to say that we would not include it in our work load in the future. The informal briefing route would enable the committee to consider the issue and put it on the agenda for future meetings so that we can have input into the cancer plan. Following the informal briefing, we could take formal oral evidence on a time scale that we could achieve. I do not want the committee to take on a work load that it cannot achieve.

Nicola Sturgeon:

This issue might have been discussed before I was on the committee. What are the committee's plans for considering the health plan when it is published on Thursday?

Cancer will come up as part of that plan. I would accept what you are proposing if, in a more structured way, we were going to feed into what is essentially the blueprint for the health service over the next few years. We must have a role in the health plan and the cancer plan. We must clarify our role.

Dr Simpson:

We need to start by clarifying the precise nature of the plans: are they finalised, or will the cancer plan, for example, be a draft set of proposals for further consultation? If the latter is true, we should take evidence on that plan when it is published. It is crucial that we examine the first Scottish health plan. We must set aside time in the spring to do that and to hear the reactions to it—the newspapers are talking about it already. Some huge changes will be proposed, and we need to debate the subject.

The Convener:

I am sorry if I did not make myself clear. I assumed that the committee would examine the health plan at some point. That will be a significant document in regard to what we want to happen in the Scottish health service, and we will have to comment on it. The question is where the cancer plan fits in. We need clarification on that, which the clerks will provide.

The committee's work programme is an on-going item. Periodically, we have raised it in the committee, and can do so again in January. One area of work is current petitions. If we deal with those today, we will have a clearer idea of where we are with them, and can feed them into our work plan, with the background knowledge that we have to cover the health plan and the regulation of care bill. Those matters will be our substantive work for the beginning of next year.

Mary Scanlon:

Some time ago—in September, I think—when we were considering the joint future group and the ministerial statement on personal care, we asked for an idea of when the Executive intended to issue the plans, so that we could co-ordinate our work and not be bounced into them. Parliament is often presented with things that we have not even heard of. We are constantly reacting rather than being proactive. I thought that one of the features of the Scottish Parliament was that committees worked together, fed into plans, had a say in the consultation process, and then scrutinised the outcome. In fact, we are being kept almost in the dark. The debate then becomes very confrontational. Committee members seek to be stakeholders and to make an input into the plans. Rather than being bounced into being reactive, we should be able to feed into the plans in a positive, helpful manner.

Someone has to determine the role of the committee. Are we part of the process, or do we exist to react to it? Nicola Sturgeon has made a good point. Cancer is one of the top three clinical priorities. Either we wait for the cancer plan to be published, and then yell at one another in the chamber, or we do something positive, by listening to people and making an input into the plan. I prefer the latter option.

The Convener:

I suggest that we write to the minister to reiterate the points that Mary Scanlon and Nicola Sturgeon have made, which echo the points that we made previously to the minister. As a result of those protestations, some months ago, we received forward work plans from the Executive. However, the clerk informs me that in reply to our most recent request for information, we received a bland paragraph about modernising the NHS, which gave no dates. We will pursue that matter.

Members will know that there have been difficulties in liaison between the committee and the Executive, which culminated in six or seven letters on hepatitis C going unanswered by the Executive, until the matter was raised with the minister personally. We will make the point again to the minister that it is impossible for a committee to feed into the process properly if it does not know what the Executive's plans are. We will ask for that information. In our first year, we were given a year-long work programme by the Executive, which was useful. However, for the committee's second year, that has not been forthcoming, despite our requests.

Can we discuss our own work plan at the next meeting?

Yes. We discuss the work plan periodically, and I will bring it forward to the January meeting.

Dorothy-Grace Elder:

When you write to the Executive, would you care to add that committee membership will be cut in the new year, unless there is some intervention to change that? Today's discussion on our heavy work load makes a good case for committee membership not to be cut, so that we have enough people to continue, for instance, with our reporter system.

The Convener:

Shall we arrange for an informal briefing from Macmillan Cancer Relief and the Cancer Research Campaign, which we could open up to other organisations as well? Members should e-mail me or the clerk with other individuals or organisations that they think it would benefit us to hear from. We will have that briefing as early in the new year as we can. After the briefing, we will decide whether to take any further oral evidence. By that time, we will have information on the timing and remit of the cancer plan, and we will able to feed into that, if time allows. Do members agree to all that?

Members indicated agreement.

The Convener:

We move now to possible inquiry topics. We have received a letter from Professor John Fabre of Guy's, King's and St Thomas' School of Medicine on the subject of elective ventilation for organ donation. Richard Simpson is our organ donation reporter.

Dr Simpson:

I continue to have discussions with a number of organisations. I have been in communication with Professor John Fabre and Mr Engeset in Aberdeen, who is especially keen on this subject. I suggest that we do not have a specific inquiry on it. I have another two meetings arranged. I hope to meet Lord Hunt to discuss the UK's approach, which has yet to be settled. As members know, the minister has announced the intention of beefing up the opt-in system, and we will see what happens with that.

I hope to have a report for the committee some time in February, around the time when we are scheduled to report on the regulation of care bill—28 February, I believe. After we discuss that bill, I hope that we will have an evidence-taking meeting. We can then decide whether we wish to proceed with that as a committee bill. I am not asking the committee to comment on that at the moment; I am just letting members know my thinking.

A range of options in that area could benefit from a committee-style approach.

Dr Simpson:

I have met people from the Scottish renal group—physicians, nurses and technicians. I have met the transplant co-ordinators, who have been extremely helpful. I will meet intensive care unit nurses early in January. There will be a national meeting of ITU nurses at the beginning of March, but that will be after the report is out. Things are moving forward quite well.

The Convener:

We shall pass this particular letter to Richard Simpson as part of his continuing inquiry.

Diabetes UK has raised points about local provision in the Glasgow area and about a lack of data on the number of people suffering from diabetes. Does the committee agree that I should extract some questions from the letter from Diabetes UK and pass them on to the Executive on behalf of the committee?

Members indicated agreement.

The Convener:

Previously, the committee has taken the view that questions of local provision, of acute services reviews and so on, should not be dealt with at this committee, unless they were relevant to national strategic issues that we felt could benefit from committee work. Are there any comments on the Glasgow royal infirmary request? Are members happy to follow the same line as before?

Members indicated agreement.

Iain Smith asked about exemption from prescription charges.

I understood that the list of medicines that were exempt was decided by Westminster. Is Iain Smith saying that that is a devolved matter?

Richard Simpson may be able to clarify that.

Prescription charges fall within the remit of the Scottish Parliament; they are not a reserved matter.

Did you say prescription charges?

Dr Simpson:

Yes. Prescription charges relate to exemption and, as I understand it, we can determine our own exemptions. I raised the matter with the minister in August 1999 and indicated that in due course I would want to discuss in committee and in the Parliament the whole area of prescription exemption and charges. Members may know that the matter was also raised in the Finance Committee during discussions on the budget, as the sums involved are netted off within the health budget and are not specified. That lack of clarity was disturbing.

It is an issue that we should return to. It is long overdue for consideration. The Executive itself may propose a study of that area, but I would like us to begin by raising the matter privately with the minister to see what her intentions are. Only if she says that it is not a priority for the Executive should we proceed to discuss what we might be able to do in that area.

I would support that.

The Convener:

I am happy to support that, but I would prefer to raise the matter with the minister formally. I do not see why we cannot write to her about it. We have received a formal request about the issue and I think that we should treat it formally by writing to the minister and asking whether the Executive has any plans in that area. We should also flag up the issue with the researchers, saying that we would appreciate any background research that is available.

At the same time, we can ask the Executive for a rundown of the present situation and for clarification that the issue is actually within the Scottish Parliament's remit. I certainly agree that it is likely that that is the case; that is the situation in Wales, so I do not see why it should not also be the case in Scotland. We shall ask for clarification on those points and ask what the Executive plans to do.

We have received a letter from Cathy Jamieson about optician practice. I suggest that we simply note that letter. At some point in the future, we may want to come back and discuss opticians.

Margaret Jamieson:

I think that you are missing the point. What Cathy Jamieson is concerned about is the whole issue of somebody challenging the system whereby opticians are able to make any recommendation without there being any recourse for the individual other than through their MSP. That takes us back to our previous discussions about the ombudsman. This is another issue that falls in that area.

We can link that into our previous points about the ombudsman. We shall ask for clarification of what recourse people have if they have a complaint against a high-street optician.

Margaret Jamieson:

Cathy Jamieson's letter also raises the question of how some supermarket opticians are operating and how they are governed. The individual in question raises the valid point that they were given the cheaper option, but that might not always be the option that is required.

The Convener:

We shall include that issue in our on-going work on the ombudsman and get some clarification on the matter.

We also had a request—it should have come in in writing by now—from Andrew Welsh to discuss hospital-acquired infections. He drew my attention to the fact that the Public Accounts Committee of the House of Commons has just completed an inquiry into the management and control of hospital-acquired infection in acute NHS trusts in England. Andrew wondered whether we were interested in examining hospital-acquired infection in Scotland. He intimated that he would like the issue to be investigated by either the Health and Community Care Committee or the Audit Committee. Do members have suggestions?

Margaret Jamieson:

I think that we have missed the boat. Audit Scotland produced a report on domestic services in the health service and their effect on hospital-acquired infections. That was published well in advance of the report from Westminster. The Audit Committee could deal with the issue, because Audit Scotland undertook that report.

Ben Wallace:

I read Audit Scotland's report. There are several failings in how we prevent and treat new infections. Audit Scotland spotted the problem and said that something has to be done about it. One of its key recommendations is that it is down to local health boards to produce a plan to combat infection. I am sure that inconsistency in treating infections will not lead to their extinction; indeed, it will probably encourage them. Treating a patient one way in Perth and then moving them to Falkirk and treating them differently there will do no good.

Drugs are coming on to the market to treat the infection—I think that they are available in America already. Audit Scotland failed to hone down the number of people who are dying of these infections or who are entering hospital and acquiring them. I thought that the report was quite loose. It said simply, "Here it is." The onus should be on the Executive to produce a better and more co-ordinated plan and a long-term strategy. The issue is real and should not be swept under the carpet.

Mary Scanlon:

Hospital-acquired infection seriously damages not only the patient, but the health services. I have heard of people whose stay in hospital has been prolonged by three months because of hospital-acquired infections. The issue is serious—many people are more worried about methicillin-resistant staphylococcus aureus than about surgery.

I am pleased that we are now auditing hospital-acquired infections, but I would still like the number of people infected in each hospital to be published—my concern for that has persisted through written questions. The approach is different in each hospital and some infection teams do not meet the recommended standards. I feel strongly that it is time to name and shame hospitals, to give patients trust and confidence when they go into hospital and to encourage hospitals to get their act together.

Nicola Sturgeon:

I agree with Mary Scanlon. This is a big issue. The briefest of conversations with any hospital risk manager will give a horrifying insight into some of the decisions that are taken daily in hospitals and that are impacting on the incidence of hospital-acquired illness. We could examine the issue.

Margaret Jamieson is right to mention the Audit Scotland report. I read it as well. It does a reasonable job of assessing the scale of the problem, but it is arguable that Audit Scotland's remit does not include examining why the infections are occurring and what can be done to cut their incidence. That would be where we come in. Perhaps the issue is not our top priority, but we could consider it, because it costs the NHS horrendous amounts of money and it prolongs people's stays in hospital. I have spoken to risk managers about decisions that are taken in hospitals as a matter of course. Far from cutting the incidence of hospital-acquired infections, those decisions are probably increasing it and building infections into the risk management process. The subject is ripe for our scrutiny.

Dorothy-Grace Elder:

We know that there is concern in some areas, particularly about operating theatres. However, it is not just a question of name and shame—it is not necessarily that people are doing something wrong. The lack of a consultant microbacteriologist—there are not enough of them in Scotland—the distance that samples have to be sent for testing or the frequency of lab tests, might be the problem. I go back to the point about who is at the top of the tree. Many consultant places have been cut, including in microbacteriology, which is essential to the health of patients.

Ben Wallace:

The onus is on the Executive. It is unfair to name and shame a hospital. That would cause panic, particularly if people have only one hospital that they can go to. I would not like to be the GP who is told that a certain hospital is the death hospital and that the patient wants to go somewhere else. The Executive must address the problem nationally, rather than leave it up to health boards that might be strapped for cash and do not have the consultants.

Margaret Jamieson:

I do not think that it is as sophisticated as Dorothy-Grace Elder is making out. It is not as if MRSA would disappear if we had plenty of microbacteriologists. The Audit Scotland report mentions domestics on wards, their training and so on. We need to start at that level. If we have clean hospitals, the incidence of hospital-acquired infection will reduce dramatically. That is an area where health boards and trusts must actively recruit people. That would give us the opportunity to eradicate hospital-acquired infections and only in certain areas—particular types of surgery, for example—would MRSA be prevalent. We can take a broad brush approach.

What actions have the Executive taken to implement the recommendations made by Robert Black? Once we know that, we can make a judgment.

The Convener:

I suggest that that is the appropriate course of action. We should find out what the Executive has been doing. We can revisit the issue when we consider our work plan in January. The committee recognises that this is an important issue. In the future, we might want to consider it further. We can impress on the Executive the need for a swift response.

It is clear that the House of Commons report and others have said that handwashing regimes are very poor. It comes down to a very basic level of hygiene on the part of domestics and individual clinicians. There are also wider issues, as Dorothy-Grace has mentioned.

Dr Simpson:

The Accounts Commission has produced several reports over the past few years, one of which was on the matter in hand. We should write to the Accounts Commission and ask at what point it thought it reasonable to reconsider the extent to which a report had been implemented. What role does the Accounts Commission take in following up its reports? The Executive has a role, as does the Accounts Commission. I am thinking of operating theatre time, which is crucial to waiting times and lists.

When Robert Black gave evidence, we asked him to indicate at what point it would be reasonable to go back and reconsider the issues. However, we have not heard back from the Accounts Commission on that.

The Convener:

There have been other reports. We considered an excellent report on prescribing and an Accounts Commission report into bank and agency nursing. If both those reports were followed through, the health service would make considerable savings and possibly provide a better service.

We have been contacted by the Haemophilia Society, which is concerned about the Executive's report into haemophilia sufferers who have contracted hepatitis C. The issue comes up again later in our agenda, under petitions. Would members prefer to deal with it when we come to that item, so that we can discuss both items together?

Members indicated agreement.

The next two contacts are from the General Dental Council and the Scottish Dermatolological Society—I seem to have my teeth in the wrong way. The SDS asks us simply to note its role. I think that we should note both of those contacts.

Mary Scanlon:

We discussed, once, whether we should ask someone from the British Dental Association to meet us. I suggest that we tie that in with the dental action plan and the work force planning review, both of which are excellent documents. As dentistry is so important to Scotland, could we come back to this issue in the spring, in order to tie in—

The Convener:

That is a specific request. For clarification, the clerks are still trying to organise an informal briefing, to which we agreed, from the BDA. The best solution would be for the committee to get that briefing from the BDA, which we envisage will be an umbrella briefing on dentistry. Dentistry and the dental action plan have been raised in Parliament on a couple of occasions in the past few weeks and I suggest that we simply note these contacts. Are members agreed?

Members indicated agreement.